⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2000644 | 0.77 | — | — | |
| SCHEMBL4412928 | 0.77 | — | — | |
| SCHEMBL2000638 | 0.77 | — | — | |
| SCHEMBL39411 | 0.74 | — | — | |
| SCHEMBL28574239 | 0.72 | — | — | |
| SCHEMBL9013515 | 0.72 | — | — | |
| SCHEMBL29271871 | 0.72 | — | — | |
| SCHEMBL2087140 | 0.72 | — | — | |
| SCHEMBL25496315 | 0.72 | — | — | |
| SCHEMBL31266587 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117957234-A | Thienopyrrole compounds | 吉利德科学公司 | 2024-04-30 | — | — | CN | claimed |
| CN-116783202-A | Thienopyrrole compounds | 吉利德科学公司 | 2023-09-19 | — | — | CN | claimed |
| EP-3894396-A1 | 2-OXOQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS | Ideaya Biosciences, Inc. (US) | 2021-10-20 | — | — | EP | claimed |
| WO-2020123395-A1 | 2-OXOQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS | IDEAYA BIOSCIENCES, INC. (US) | 2020-06-18 | — | — | WO | claimed |
| US-5527899-A | STABILIZATION THE SINGLE-STRAND OLIGONUCLEOTIDE TO EXONUCLEASE DEGRADATION | GILEAD SCIENCES, INC. (US) | 1996-06-18 | — | — | US | claimed |
| US-5399676-A | DNA sequence identification | GILEAD SCIENCES (US) | 1995-03-21 | — | — | US | claimed |
| CN-117957234-A | Thienopyrrole compounds | 吉利德科学公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-116848139-A | BCMA/TACI antigen binding molecules | 蜂鸟生物科技私人有限公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-116783202-A | Thienopyrrole compounds | 吉利德科学公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-113712241-B | Tobacco tar prepared by heating herbal raw materials with assistance of atomizing agent | 中国烟草总公司郑州烟草研究院 | 2022-09-30 | — | — | CN | disclosed |
| CN-113712241-A | Tobacco tar prepared by heating herbal raw materials with assistance of atomizing agent | 中国烟草总公司郑州烟草研究院 | 2021-11-30 | — | — | CN | disclosed |
| WO-2015121379-A2 | METHODS OF IMPROVING PRODUCTION OF VANILLIN | EVOLVA SA (CH) | 2015-08-20 | — | — | WO | disclosed |
| US-5721218-A | Oligonucleotides with inverted polarity | GILEAD SCIENCES, INC. (US) | 1998-02-24 | — | — | US | disclosed |
| US-5527899-A | STABILIZATION THE SINGLE-STRAND OLIGONUCLEOTIDE TO EXONUCLEASE DEGRADATION | GILEAD SCIENCES, INC. (US) | 1996-06-18 | — | — | US | disclosed |
| US-5399676-A | DNA sequence identification | GILEAD SCIENCES (US) | 1995-03-21 | — | — | US | disclosed |
| EP-0539371-A1 | TRIPLE HELIX FORMATION IN OLIGONUCLEOTIDE THERAPY | GILEAD SCIENCES, INC. (US) | 1993-05-05 | — | — | EP | disclosed |
| WO-1991006626-A2 | TRIPLE HELIX FORMATION IN OLIGONUCLEOTIDE THERAPY | GILEAD SCIENCES, INC. (US) | 1991-05-16 | — | — | WO | disclosed |